- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 8 - A Diverse Patient Population and Its Challenges
According to Dr. Michael Weber, many patients will often present at the physician’s office with previously undiagnosed or unrecognized risk factors, which occurs frequently with high blood pressure, lipid disorders, and diabetes. Consequently, initial therapeutic strategies must be aggressive to properly control those who are truly at high risk. However, according to the panelists, not all patients are the same, not all patients are diagnosed at the same time, and there are countless variables that may impact the trajectory of a disease state. Therefore, it is vital to emphasize and drive personalized medicine with individualized goals. While there are contentions among different patient populations regarding the merits of pharmacotherapy and lifestyle modifications, the panelists believe that a comprehensive and balanced strategy is what will garner the most beneficial outcomes.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates
March 6th 2025Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Read More
